EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Maria Consuelo Pintado iD, Inmaculada Lasa Unzúe, Remedios Gómez Sanz, Manuel Diez Alonso, Miguel A Ortega iD, Melchor Álvarez de Mon, Emilio Nevado Losada, Alberto Gutierrez Calvo

Journal of Clinical Medicine · 27.06.2023 · 12 (13) · 4323

DOI: 10.3390/jcm12134323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.06.2023. Verfasst von Maria Consuelo Pintado und 7 weiteren Autor:innen. Beteiligte Einrichtung: Intensive Care Unit, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ProA Capital, Halekulani S.L., MJR, European Development Regional Fund 'A way to achieve Europe', P2022/BMD-7321 (Comunidad de Madrid)..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have benefits for survival in some cancers with peritoneal metastasis. Hematologic toxicity described rate is 2 to 38%.

Methods

Patients admitted to an intensive care unit (ICU) after CRS and HIPEC over 78 months. The data recorded were demographic characteristics, the severity of illness, complete blood samples, the type of cancer and extension, HIPEC drug and temperature, ICU and hospital stay and mortality, bleeding, and the need for transfusion of blood products.

Results

Of the 96 patients included, 77.1% presented hematological complications: 8.3% leukopenia (

Schlagwörter

Stichwörter der Autor:innen

cytoreductionhyperthermic intraperitonealpostoperative complicationsprognosis

Autor:innen und Institutionen

  • Intensive Care Unit, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain.
  • Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, 28801 Alcalá de Henares, Spain.
  • Department of General and Digestive Surgery, General and Digestive Surgery, Hospital Universitario Príncipe de Asturias, 28805 Alcalá de Henares, Spain.
  • Ramón y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain.
  • Inmune System Diseases-Rheumatology and Internal Medicine Service, Hospital Universitario Príncipe de Asturias (CIBEREHD), 28806 Alcalá de Henares, Spain.

ORCID-Profile: Maria Consuelo Pintado, Miguel A Ortega

Förderung

  • ProA Capital, Halekulani S.L., MJR
  • European Development Regional Fund 'A way to achieve Europe'
  • P2022/BMD-7321 (Comunidad de Madrid).
  • ProA Capital
  • Halekulani S.L.
  • MJR
  • European Development Regional Fund “A way to achieve Europe”
  • Comunidad de Madrid

Zitieren

APA

Pintado, M. C., Lasa Unzúe, I., Gómez Sanz, R., Diez Alonso, M., Ortega, M. A., Álvarez de Mon, M., Nevado Losada, E., & Gutierrez Calvo, A. (2023). Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Clinical Medicine, 12(13), 4323. https://doi.org/10.3390/jcm12134323

Vancouver

Pintado MC, Lasa Unzúe I, Gómez Sanz R, Diez Alonso M, Ortega MA, Álvarez de Mon M, et al. Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Journal of Clinical Medicine. 2023;12(13):4323. doi:10.3390/jcm12134323

BibTeX
@article{Pintado2023,
  author = {Pintado, Maria Consuelo and Lasa Unzúe, Inmaculada and Gómez Sanz, Remedios and Diez Alonso, Manuel and Ortega, Miguel A and Álvarez de Mon, Melchor and Nevado Losada, Emilio and Gutierrez Calvo, Alberto},
  title = {Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {13},
  pages = {4323},
  doi = {10.3390/jcm12134323}
}
Kostenlos starten →